DeVere Company, Inc. – FDA 483, Jun 4, 2025
DeVere Company, Inc. in Janesville, WI, an OTC drug manufacturer, was cited for significant deficiencies across its quality system during an FDA inspection. The firm failed to follow its stability testing program, lacked adequate written procedures and controls for its quality unit and manufacturing processes, and did not ensure proper laboratory controls, including testing of raw materials and finished products for impurities and microbial contamination. These issues indicate a systemic breakdown in ensuring the identity, strength, quality, and purity of its OTC antimicrobial hand sanitizer drug products.
ID · b7ae4126-703e-4cd1-aa02-4de201a08729
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.